English | Español
Press release submission | Aug 13, 2019

SIGNANT HEALTH: Launches Partner Program to Team with Clinical Research Organizations (CROs) Committed to Improving Clinical Trials with Patient-Centric Technology
Press release submission | Aug 1, 2019

I-MAB BIOPHARMA: I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in a Phase 1 Trial of the CD73 Antibody TJD5 in the U.S. in Patients with Advanced Solid Tumors
Press release submission | Jul 19, 2019

BACKPACK HEALTH: Patients with Hereditary Hemorrhagic Telangiectasia (HHT) Gain Full Access to Critical Health Data Management Platform

Press release submission | Jul 12, 2019

EIP PHARMA, INC.: Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Press release submission | Jul 1, 2019

EXPERIMENTAL BIOLOGY AND MEDICINE: A New Target for the Treatment of Idiopathic Pulmonary Fibrosis
Press release submission | Jun 28, 2019

AJ VACCINES: Will Contribute to Global Polio Eradication With its Innovative Vaccine Picovax
Press release submission | Jun 21, 2019

FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH: New research provides insight into immunity of lupus patients
Press release submission | Jun 14, 2019

JOHNSON & JOHNSON: Janssen reports top-line Phase 3 results for TREMFYA® (guselkumab) in adults with active psoriatic arthritis

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’